CompletedNot a drug-phase studyMS (type not specified)NCT07804264

What it found

No result found

We found no results in the registry or in papers.

What was tested

Treatment tested

  • Short sprint interval training

What it measured

Main measures

  • Change in Symbol Digit Modalities Test Oral Score

    Baseline and Week 4

    Thinking and memory
  • Change in Fatigue Severity Scale Score

    Baseline and Week 4

    Fatigue
  • Change in Timed 25 Foot Walk Time

    Baseline to Week 4

    Disability progressionWalking and mobility
  • Change in the Six-Spot Step Test Time

    Baseline and Week 4

    Walking and mobility

Other measures (5)

  • Change in Handgrip Strength

    Baseline and Week 4

    Arm and hand functionPhysical function
  • Change in Lower-limb Muscle Power

    Baseline to Week 4

    Physical function
  • Change in Lower-limb endurance and strength

    Baseline to Week 4

    Physical function
  • Change in Cardiorespiratory fitness

    Baseline and Week 4

    Physical function
  • Change in Plantar flexor strength-endurance

    Baseline to Week 4

    Physical function

Who could take part

MS (type not specified) · 18 to 65

Inclusion Criteria: * Diagnosis of multiple sclerosis according to the revised McDonald criteria; Expanded Disability Status Scale score 0-3.5. * Age 18-65 years. * No multiple sclerosis relapse or exacerbation in the previous month. Exclusion Criteria: * Neurological disease other than multiple sclerosis. * Cognitive impairment preventing completion of tests or questionnaires. * Neurological, orthopedic, or visual impairments affecting gait.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The goal of this clinical trial is to learn whether a short sprint interval training protocol on a cycle ergometer can improve physical function, walking, muscle strength, exercise capacity, fatigue, cognitive processing speed, and patient-reported outcomes in people with multiple sclerosis. The main questions it aims to answer are: 1. Does short sprint interval training improve walking performance, lower-limb coordination, muscle strength, exercise capacity, fatigue, and cognitive processing speed in people with multiple sclerosis? 2. How do participants respond to short sprint interval training in terms of heart rate, power, cadence, perceived exertion, and affective valence? 3. What adverse events or unintended effects, if any, occur during the intervention? Researchers will compare short sprint interval training with usual physical activity to see if this exercise program improves physical, cognitive, and patient-reported outcomes. Participants will: 1. Be randomly assigned to either a short sprint interval training group or a usual physical activity group. 2. Complete assessments before and after the 2-week training period. 3. Continue their usual physical activity if they are assigned to the control group. 4. Complete 6 supervised exercise sessions over 2 weeks if they are assigned to the short sprint interval training group. 5. During each exercise session, perform short 5-second high-intensity cycling sprints on a recumbent cycle ergometer, separated by recovery periods. 6. Complete walking, strength, stepping, calf endurance, fatigue, and cognitive processing speed assessments.

Papers

Loading reviews and guidelines…

History

  1. Status changed from Recruiting to Completed
  2. Primary completion date changed from 2026-10-01 to 2026-10-19
  3. Completion date changed from 2026-10-01 to 2026-10-19
  4. Result signal changed from ongoing to completed_recent_or_undated
  1. Started

    Sept 2026

  2. Main results due

    Oct 2026

  3. Finished

    Oct 2026

Assembled by software from public sources and not checked by people. Each record links to its source. Report an error